{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02052960: Phase 2 Interventional Completed Carcinoma, Squamous Cell of Head and Neck
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:peginterferon alfacon-2 [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:varisacumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03538899: Phase 1/Phase 2 Interventional Recruiting Severe Combined Immunodeficiency
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00012454: Phase 2 Interventional Terminated Cerebrovascular Accident
(2001)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03486899: Phase 2 Interventional Completed Liver Fibrosis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04316364: Phase 3 Interventional Recruiting Non-Small-Cell Lung Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04570839: Phase 1/Phase 2 Interventional Completed Endometrial Neoplasms
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03780972: Phase 1 Interventional Completed Rhegmatogenous Retinal Detachment - Macula Off
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02273960: Phase 1/Phase 2 Interventional Completed Immune Thrombocytopenic Purpura
(2014)
Source URL:
Class:
PROTEIN
